Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning

This article was originally published in The Tan Sheet

Executive Summary

Ron Fugate sees UrgentRx not only using some of the strongest marketing strategies he’s known for building a successful consumer health care product brand, but also making headway in new areas important to driving sales for new products.

You may also be interested in...



Synergy CHC Has UrgentRx Ticket To Enter OTC Market

Synergy also acquires Australian brand Flat Tummy Tea. Both deals partly are financed through a $5.5m loan from Knight Therapeutics, a Canadian firm that in January also provided Synergy with a $6m loan to acquire the Focusfactor dietary supplement brand.

Synergy CHC Has UrgentRx Ticket To Enter OTC Market

Synergy also acquires Australian brand Flat Tummy Tea. Both deals partly are financed through a $5.5m loan from Knight Therapeutics, a Canadian firm that in January also provided Synergy with a $6m loan to acquire the Focusfactor dietary supplement brand.

Pharmabox, SuppNow Match Self-Care Demand With Self-Serve Retail

SuppNow and Pharmabox self-serve kiosks could point to the near-future of supplement and OTC drug sales, allowing consumers to avoid waiting in lines or for deliveries. SuppNow offers supplements at gyms in California; Pharmabox vends OTC drugs in high-traffic consumer areas.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel